Morgan Stanley Lowers Sempra's Price Target Amid Analyst Downgrades Morgan Stanley reduced its price target for Sempra (NYSE:SRE) from $100 to $85, while maintaining an “overweight” rating. Other firms, including UBS and Wells Fargo, also downgraded their ratings, citing concerns over valuation. Sempra’s recent earnings report showed a slight revenue increase, but analysts remain cautious.3